1. Home
  2. CW vs BNTX Comparison

CW vs BNTX Comparison

Compare CW & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Curtiss-Wright Corporation

CW

Curtiss-Wright Corporation

HOLD

Current Price

$663.03

Market Cap

24.2B

Sector

Technology

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$85.61

Market Cap

22.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CW
BNTX
Founded
1929
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.2B
22.8B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
CW
BNTX
Price
$663.03
$85.61
Analyst Decision
Buy
Strong Buy
Analyst Count
6
13
Target Price
$603.00
$134.15
AVG Volume (30 Days)
260.4K
1.3M
Earning Date
05-06-2026
03-10-2026
Dividend Yield
0.14%
N/A
EPS Growth
21.99
N/A
EPS
12.87
N/A
Revenue
$2,391,336,000.00
N/A
Revenue This Year
$10.39
N/A
Revenue Next Year
$7.87
$4.76
P/E Ratio
$51.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$266.88
$79.81
52 Week High
$730.12
$124.00

Technical Indicators

Market Signals
Indicator
CW
BNTX
Relative Strength Index (RSI) 44.25 33.71
Support Level $640.00 $79.81
Resistance Level $676.54 $113.12
Average True Range (ATR) 27.26 2.69
MACD -3.78 -0.31
Stochastic Oscillator 26.53 34.83

Price Performance

Historical Comparison
CW
BNTX

About CW Curtiss-Wright Corporation

Curtiss-Wright Corporation delivers engineered products and services to commercial, defence, power generation, and other industrial markets. It offers industrial vehicle components, control systems, weapons handling systems, pumps, valves, and other solutions. The company has three reportable segments based on the markets serviced: Naval & Power, which provides coolant pumps, power-dense compact motors, generators, secondary propulsion systems, pumps, pump seals, valves, control rod drive mechanisms, and fastening systems that also generate maximum revenue for the company; its other segments are Aerospace & Industrial and Defense Electronics. Geographically, the company generates its key revenue from the United States of America, followed by the United Kingdom and other countries.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: